Issue link: https://www.e-digitaleditions.com/i/1254974
18 June 2020 Inhalation 29. Réminiac F, Vecellio L, Loughlin RM, Le Pennec D, Cabrera M, Vourc'h NH, et al. Nasal high flow nebulization in infants and toddlers: An in vitro and in vivo scintigraphic study. Pediatric Pulmonology. 2017;52(3):337-344. 30. Bennett G, Joyce M, Sweeney L, MacLough- lin R. In vitro determination of the main effects in the design of high-flow nasal therapy systems with respect to aerosol performance. Pulmonary erapy. 2018;4(1):73-86. 31. Bennett G, Joyce M, Sweeney L, MacLoughlin R. In vitro study of the effect of breathing pattern on aero- sol delivery during high-flow nasal therapy. Pulmonary erapy. 2019;5(1):43-54. 32. Li J, Gong L, Fink JB. e ratio of nasal cannula gas flow to patient inspiratory flow on trans-nasal pulmo- nary aerosol delivery for adults: An in vitro study. Phar- maceutics. 2019;11(5):225. 33. Lavelle A, Bonnet J-F, Murphy B, O'Sullivan E, MacLoughlin R. Effect of flow rate and nebuliser posi- tion on lidocaine deposition using the Aerogen ® Solo™ nebulizer. Trends in Anaesthesia and Critical Care. 2020;30:e191-e2. 34. McGrath JA, O'Toole C, Bennett G, Joyce M, Byrne MA, MacLoughlin R. Investigation of fugitive aerosols released into the environment during high- flow therapy. Pharmaceutics. 2019;11(6):254. 35. Leonard S, Atwood CW Jr, Walsh BK, DeBellis RJ, Dungan GC, Strasser W, Whittle JS. Prelimi- nary findings of control of dispersion of aerosols and droplets during high velocity nasal insufflation ther- apy using a simple surgical mask: Implications for high flow nasal cannula. Chest. 2020 Apr 2. [Epub in advance of print publication]. Ronan MacLoughlin, PhD, MBS is Senior Science Man- ager, Aerogen Limited, Galway Business Park, Dangan, Galway, H91 HE94, Ireland; Senior Honorary Lecturer, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland; Adjunct Associate Professor, School of Pharmacy and Pharmaceutical Sci- ences, Trinity College, Dublin, Ireland; rmacloughlin@ aerogen.com. James B. Fink, PhD, RRT, FA ARC, FCCP is Chief Scientific Officer, Aerogen Pharma Corporation, 1660 S. Amphlett Blvd., Suite 360, San Mateo, CA 94402, United States; Adjunct Professor, Division of Respiratory Care, Texas State University, Round Rock, Texas, United States; Adjunct Faculty, Division of Respiratory er- apy, Rush Medical School, Chicago, IL, United States; Visiting Professor, Department of Physical erapy, Uni- versidade Federal de Pernambuco, Recife, Pernambuco, Brazil; jfink@aerogenpharma.com. 24. Réminiac F, Landel C, Gensburger S, Bocar T, Mordier L, Philippe M, et al. Optimal delivery of salbutamol with a pressurized metered dose inhaler within a high flow nasal therapy circuit. C51 respira- tory failure: high flow oxygen, liberation, non-invasive, and prolonged ventilation. American oracic Society. 2016. p. A5313-A. 25. Dugernier J, Hesse M, Jumetz T, Bialais E, Roe- seler J, Depoortere V, et al. Aerosol delivery with two nebulizers through high-flow nasal cannula: A ran- domized cross-over single-photon emission computed tomography-computed tomography study. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2017;30(5):349-358. 26. Bennett G, Joyce M, Fernández Fernández E, MacLoughlin R. Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy. Intensive Care Medicine Experimental. 2019;7(1):20. 27. Bhashyam AR, Wolf MT, Marcinkowski AL, Sav- ille A, omas K, Carcillo JA, et al. Aerosol delivery through nasal cannulas: An in vitro study. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2008;21(2):181-188. 28. Alcoforado L, Ari A, Barcelar JdM, Brandão SCS, Fink JB, de Andrade AD. Impact of gas flow and humidity on trans-nasal aerosol deposition via nasal cannula in adults: A randomized cross-over study. Pharmaceutics. 2019;11(7):320. www.inhalationmag.com The Inhalation 123 e-newsletter previews upcoming conferences, highlights technical articles in Inhalation and more. Please watch for it in your inbox every other month. Sign up now by emailing your name, company name and email address to kmyers@cscpub.com.